APA
Mason B., Flach S., Teixeira F. R., Manzano Garcia R., Rueda O. M., Abraham J. E., Caldas C., Edwards P. A. W. & Laman H. (20200727). Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. : Cellular and molecular life sciences : CMLS.
Chicago
Mason Bethany, Flach Susanne, Teixeira Felipe R, Manzano Garcia Raquel, Rueda Oscar M, Abraham Jean E, Caldas Carlos, Edwards Paul A W and Laman Heike. 20200727. Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. : Cellular and molecular life sciences : CMLS.
Harvard
Mason B., Flach S., Teixeira F. R., Manzano Garcia R., Rueda O. M., Abraham J. E., Caldas C., Edwards P. A. W. and Laman H. (20200727). Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. : Cellular and molecular life sciences : CMLS.
MLA
Mason Bethany, Flach Susanne, Teixeira Felipe R, Manzano Garcia Raquel, Rueda Oscar M, Abraham Jean E, Caldas Carlos, Edwards Paul A W and Laman Heike. Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. : Cellular and molecular life sciences : CMLS. 20200727.